Epicardial fat tissue in patients with psoriasis:a systematic review and meta-analysis

Lipids in Health and Disease

Volumn 15, Issue 1, 2016, Pages

  Wang, Xiaoxue ^a   Guo, Zaipei ^a   Zhu, Zexin ^a   Bao, Yuting ^a   Yang, Beichen ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Epicardial fat tissue; Meta analysis; Psoriasis

Indexed keywords

ADIPOSE TISSUE; ADULT; CARDIOVASCULAR DISEASES; CLINICAL TRIAL (TOPIC); COMPLICATION; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; PATHOLOGY; PERICARDIUM; PSORIASIS; RISK FACTOR; X-RAY COMPUTED TOMOGRAPHY;

ADIPOSE TISSUE; ADULT; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PERICARDIUM; PSORIASIS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84971507713     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-016-0271-y     Document Type: Review

References (25)

1. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141(12):1537-41.
2. Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res (Hoboken). 2011;63(12):1729-35.
3. Friedewald VE, Cather JC, Gelfand JM, Gordon KB, Gibbons GH, Grundy SM, et al. AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol. 2008;102:1631-43.
4. Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol. 2009;145:700-3.
5. Miller IM, Ellervik C, Yazdanyar S, Jemec GB. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol. 2013;69(6):1014-24.
6. Horreau C, Pouplard C, Brenaut E, Barnetche T, Misery L, Cribier, et al. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013;27 Suppl 3:12-29.
7. Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1.
8. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2(10):536-43.
9. Bulbul Sen B, Atci N, Rifaioglu EN, Ekiz O, Kartal I, Buyukkaya E, et al. Increased epicardial fat tissue is a marker of subclinical atherosclerosis in patients with psoriasis. Br J Dermatol. 2013;169(5):1081-6.
10. Akyildiz ZI, Seremet S, Emren V, Ozcelik S, Gediz B, Tastan A, et al. Epicardial fat thickness is independently associated with psoriasis. Dermatology. 2014;228(1):55-9.
11. Bacakslz A, Tasal A, Sevgili E, Erdoǧan E, Onsun N, Sönmez O, et al. Epicardial fat thickness in patients with psoriasis vulgaris. Turk Kardiyol Dern Ars. Turk Kardiyol Dern Ars. 2014;42(1):47-54.
12. Balci A, Celik M, Balci DD, Karazincir S, Yonden Z, Korkmaz I, et al. Patients with psoriasis have an increased amount of epicardial fat tissue. Clin Exp Dermatol. 2014;39(2):123-8.
13. Torres T, Bettencourt N, Mendonça D, Vasconcelos C, Gama V, Silva BM, et al. Epicardial adipose tissue and coronary artery calcification in psoriasis patients. J Eur Acad Dermatol Venereol. 2015;29(2):270-7.
14. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 updated March 2011. Available at: http://www.handbook.cochrane.org. Accessed Dec 2015.
15. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2011;8:336-41.
16. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296.
17. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829-35.
18. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735-41.
19. Alexandroff AB, Pauriah M, Camp RD, Lang CC, Struthers AD, Armstrong DJ. More thanskin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol. 2009;161(1):1-7.
20. Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol. 2007;56(4):629-34.
21. Gulliver W. Long-term prognosis in patients with psoriasis. Br J Dermatol. 2008;159(Suppl 2):2-9.
22. Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metab Res. 2008;40(7):442-5.
23. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin-a key adipkine in the metabolic syndrome. Diabetes Obes Metab. 2006;8(3):264-80.
24. Perseghin G, Lattuada G, De Cobelli F, Ntali G, Esposito A, Burska A, et al. Serum resitin and hepatic fat content in nondiabetic individuals. J Clin Endocrinol Metab. 2006;91(12):5122-5.
25. Shimabukuro M. Cardiac adioposity and global cardiometabolic risk: new concept and clinical implication. Circ J. 2009;73(1):27-34.